Special Guests

The FDA Approves Opill, Putting Women’s Health at Risk (Guest: Jim Harden)

Recently, the FDA approved an over-the-counter, abortifacient contraception, Opill, an abortifacient contraception method that prevents a woman’s healthy reproductive process from continuing and destroys a newly formed baby. And while the thought of using abortion as contraception is unpopular, in support of the FDA’s unethical decision, the pro-abortion American College of Obstetricians and Gynecologists passively admitted abortion is indeed being used as birth control. Jim Harden, CEO of CompassCare, wrote about this controversial matter in an Op-Ed to The … Read more

The Supreme Court’s Decision to Stay All Rulings Could Lead to More Pro-Abortion Violence (Guest: Jim Harden)

CompassCare CEO Rev. Jim Harden sees trouble ahead as SCOTUS decides the fate of the abortion drug Mifepristone, dubbed the “chemical coat hanger.” Executive summary/Proposed interview intro: The U.S. Supreme Court is expected to rule on Wednesday, April 19 on whether or not the abortion pill will be banned. This ruling will have far-reaching consequences since the majority of abortions in the United States are from abortion pills, not abortion surgery. CompassCare CEO Rev. Jim … Read more

Abortion Pill FDA Approval to be Revoked if GOP Attorneys General get their way (Guest: Jim Harden)

CompassCare CEO Jim Harden addresses the likelihood of the Abortion Pill becoming illegal. Woes are mounting for pro-abortion forces. First it was the reversal of Roe vs. Wade. Now Axios reports that the abortion pill might be next on the chopping block. 22 Republican state attorneys general filed a brief this week to block the FDA’s approval of mifepristone. If successful, this would result in ban in all 50 states, according to abortion advocates. Harden (or CompassCare Director … Read more

Judge May Find FDA Violated Legal Safety Protocols in Approval of Chemical Abortion (Guest: Jim Harden)

Judge Matthew Kacsmaryk, a United States District Court Judge for the Northern District of Texas is expected to rule as early as Friday, February 10 to reverse the Food and Drug Administration’s (FDA) January 3rd chemical abortion deregulation. Eight of the largest online chemical abortionists have gone on record saying they have plans to pivot away from Mifepristone to the sole use of Misoprostol. The upshot of the online chemical abortion companies’ new protocol means they intend for women to expel live … Read more

Visit Us On TwitterVisit Us On Facebook